You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

receptors 2 (HER2)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

Active, not recruiting
  • Metastatic Cancer
  • HER2 Gene Mutation
  • Neratinib Maleate
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Oct 18, 2023

HER2 Negative Breast Cancer Not Immediately Operated Trial (Ribociclib Oral Tablet)

Not yet recruiting
  • HER2 Negative Breast Cancer Not Immediately Operated
  • Ribociclib Oral Tablet
  • (no location specified)
Dec 16, 2022

Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Houston (HER2-specific T cells)

Recruiting
  • Brain Tumor, Recurrent
  • Brain Tumor, Refractory
  • HER2-specific T cells
  • Houston, Texas
  • +1 more
May 3, 2022

Breast Cancer Trial in Beijing, Guangzhou (TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen, Placebo capsules, Letrozole,

Not yet recruiting
  • Breast Cancer
  • TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen
  • Placebo capsules, Letrozole, Anastrozole, Tamoxifen
  • Beijing, Beijing, China
  • +1 more
Mar 10, 2023

Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer Trial in Algeria, Jordan, Saudi Arabia (Combination of

Not yet recruiting
  • Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
  • Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)
  • Blida, Algeria
  • +6 more
Dec 28, 2021

HER2-Positive Cancer Trial in Wuhan

Active, not recruiting
  • HER2-Positive Cancer
    • Wuhan, Hubei, China
      TongjiHospital
    Sep 7, 2022

    HER2-low in Unresectable and/or Metastatic Breast Cancer

    Not yet recruiting
    • Breast Neoplasms, Breast Cancer, Breast Carcinoma, Genes, HER-2, Genes, HER2
      • (no location specified)
      Nov 6, 2023

      Breast Cancer, HER2-positive Breast Cancer Trial in São Paulo (PHESGO)

      Not yet recruiting
      • Breast Cancer
      • HER2-positive Breast Cancer
      • São Paulo, Brazil
        Centro Paulista de Oncologia (Oncoclínicas)
      Oct 3, 2023

      HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/

      Not yet recruiting
      • HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
      • SHR-A1811
      • Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
      • (no location specified)
      Nov 6, 2023

      HER2-low in Metastatic Breast Cancer Patients

      Not yet recruiting
      • HER2-negative
        • (no location specified)
        Nov 9, 2023

        18F-HER2 PET Trial in Hangzhou (18F-HER2 PET)

        Not yet recruiting
        • 18F-HER2 PET
        • 18F-HER2 PET
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital, Zhejiang University School of med
        Aug 2, 2023

        Breast Cancer Trial (Trastuzumab Deruxtecan)

        Not yet recruiting
        • Breast Cancer
        • Trastuzumab Deruxtecan
        • (no location specified)
        Jul 10, 2023

        HER2 Expression and Clinical Pathological Characteristics in

        Recruiting
        • HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer
        • Collect HER2 expression in prostate cancer patients
        • Jinan, Shandong, China
          Qilu hospital
        Nov 17, 2023

        Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

        Not yet recruiting
        • Metastatic Colon Adenocarcinoma
        • +5 more
        • Trastuzumab
        • +2 more
        • Scottsdale, Arizona
        • +2 more
        Jan 31, 2023

        HER2-positive Advanced Breast Cancer Patients Treated With ADC

        Recruiting
        • Breast Cancer
        • HER2 expression of circulating tumor cells
        • Beijing, Beijing, China
          The Fifth Medical Center of PLA General Hospital
        Apr 18, 2023

        HER2-low Advanced Breast Cancer Patients Treated With ADC

        Recruiting
        • Breast Cancer
        • HER2 expression of circulating tumor cells
        • Beijing, Beijing, China
          The Fifth Medical Center of PLA General Hospital
        Apr 18, 2023

        Solid Tumor Trial in Shenyang (Intravenous infusion anti-HER2-CAR-T cell)

        Not yet recruiting
        • Solid Tumor
        • Intravenous infusion anti-HER2-CAR-T cell
        • Shenyang, Liaoning, China
          Phase I Clinical Trials Center Of The First Hospital of China Me
        Oct 30, 2023

        Survival Rate of HER2-Low Breast Cancer Patients

        Completed
        • HER2 Low Breast Carcinoma
        • immunohistochemistry (IHC) and in situ hybridization (ISH) Test
        • (no location specified)
        Mar 2, 2023

        Atypical Antipsychotics inGeriatric Population: What is Role of

        Recruiting
        • Neutropenia
          • Strasbourg, France
            Service de Pharmacie - Stérilisation - CHU de Strasbourg - Franc
          Oct 27, 2023

          Stomach Tumor Trial (Trastuzumab deruxtecan, Afatinib)

          Not yet recruiting
          • Stomach Neoplasm
          • (no location specified)
          Oct 16, 2023

          HER2-positive Locally Advanced Resectable Gastric Cancer Trial (KN026, KN046, XELOX)

          Not yet recruiting
          • HER2-positive Locally Advanced Resectable Gastric Cancer
          • (no location specified)
          Sep 3, 2023

          HER2-positive Gastric Cancer, Immunotherapy Trial in Shanghai (Disitamab Vedotin combined with fruquintinib and Tislelizumab)

          Recruiting
          • HER2-positive Gastric Cancer
          • Immunotherapy
          • Disitamab Vedotin combined with fruquintinib and Tislelizumab
          • Shanghai, Shanghai, China
            Fudan University Shanghai Cancer Center
          Aug 8, 2023

          HER2-HER3 Dimer in Tumour and Blood Samples From HER2 Positive

          Recruiting
          • HER2-positive Breast Cancer
          • Acquisition of blood samples and tumour tissue samples (biopsies)
          • Brighton, United Kingdom
          • +1 more
          Nov 9, 2022

          Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Boston (Cessation of anti-HER2 treatment)

          Not yet recruiting
          • Breast Cancer
          • +2 more
          • Cessation of anti-HER2 treatment
          • Boston, Massachusetts
          • +1 more
          Feb 9, 2023

          Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

          Enrolling by invitation
          • Breast Cancer
          • +7 more
          • Dnipro, Ukraine
          • +1 more
          Jun 17, 2023